Abstract
From 1961 to 1974, 245 patients with unilateral “operable” breast cancer (25% T 1, 56% T 2, 119% T 3) were treated with breast conservation and irradiation at the Gustave Roussy Institute (1961–1969) or at the Henri Mondor Hospital (1970–1974). The minimum follow-up is 15 years. Most patients with T > 3 cm underwent radiation therapy with the tumor in place, while the greater part of patients with T < 3 cm received radiation therapy after tumorectomy. The breast and draining lymph node areas received widefield telecobalt irradiation to 45 Gy. The dose to the tumor site was boosted using iridium-192 implantation. Additional irradiation was given to the internal mammary and lower axillary nodes using an electron beam. The 15 years NED survival rate was 63%, 51% and 26% for T 1, T 2 and T 3 tumors, respectively. The NED survival for T ⩽ 1 cm was 86%. The local recurrence rate was 8, 12 and 19% for T 1, T 2 and T 3 tumors, respectively. Of the patients with local recurrence, 85% underwent surgical salvage. Complications were rare. Cosmetic results were satisfactory in most patients including the T3 group. The proportion of breasts conserved among patients living NED at 15 years, was 97, 88 and 93% for T 1, T 2 and T 3 tumors, respectively. In 1980, after almost 20 years experience using breast conserving techniques, we modified our treatment policies in close collaboration with our surgical team, hel cbye extending the indications for tumorectomy and associating routine surgical exploration of the lower axilla.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.